Low back pain and FokI (rs2228570) polymorphism of vitamin D receptor in athletes

Background: Low back pain (LBP) is common in athletes. LBP can be detrimental to athletic performance and health. Factors predisposing to LBP in athletes remain elusive and require further studies. We investigated whether carriage of a specific genotype and/or allele of vitamin D receptor gene (VDR) FokI polymorphism (rs2228570) was a risk factor for LBP in athletes of different sports disciplines. Methods: This genotype/phenotype association case-control study included 60 Italian athletes (25 females and 35 males; mean age 33.9 \ub1 13.3 years; body-mass-index 23.5 \ub1 3.5 kg/m2) of which 16.7% were swimmers, 11. 7% soccer players, 11.7% volleyball players, 10.0% rugby players and other disciplines. VDR-FokI polymorphism was measured by PCR-RFLP in 24 athletes with LBP and 36 athletes without LBP episodes. Absence or presence of the FokI restriction site was denoted \u201cF\u201d and \u201cf\u201d, respectively. Other risk factors were evaluated by a questionnaire. Results: The homozygous FF genotype was found in 58.3% (14/24) of athletes with LBP versus 27.8% (10/36) of athletes without LBP, adjusted OR = 5.78, 95% CI 1.41\u201323.8, P = 0.015. The F allele was a 2-fold risk factor to develop LBP, adjusted OR = 2.55, 95% CI 1.02\u20136.43, P = 0.046, while f allele was protective. Exposure to vehicle vibrations 652 h daily, and family history of lumbar spine pathology were significant risk factors for LBP with OR=3.54, and OR=9.21, respectively. Conclusions: This is the first study in which an association between VDR-FokI polymorphism and LBP in athletes was found. Further research is needed to extend our results, and to clarify the biochemical pathways associated with how vitamin D modulates LBP in athletes. The VDR-FokI polymorphism should be considered when developing genetic focused studies of precision medicine on health in athletes

Sex differences in hydration status among adolescent elite soccer players

Hydration of athletes may affect performance and health status likely with differences among sexes. We studied the impact of sex on hydration behaviour in adolescent athletes. Hydration status and urine markers were investigated in 7 female and 7 male elite 16 years-old soccer players in temperate climate (21-24°C). Participants consumed water ad libitum during the first training session (LIB), whereas in the second session (HYD) they drunk a water amount matching 70% of sweat loss from the LIB session. Post-training performances were evaluated by Yo-Yo intermittent recovery level 1 (IR1) test and countermovement jump (CMJ). Body mass values were recorded and urine samples were collected before and after each experimental session. Males drunk a double amount of water in HYD (1.19±0.21 kg) compared to LIB (0.62±0.19 kg; p=0.001; ES=2.88), resulting in a lower percentage body mass loss (HYD -0.95±0.63% versus LIB -1.59±0.33%; p=0.044; ES=-1.35); total distance of Yo-Yo IR1 was higher, albeit not significantly, in HYD (2953±779 m) than in LIB (2103±939 m); CMJ performance was unchanged. In females, water drunk, body mass, Yo-Yo IR1 and CMJ did not vary in HYD versus LIB sessions. In adolescent males a 70% sweat replacement personalized hydration regimen reduced body mass loss and tended to improve performance, whereas in females ad libitum water drinking allowed to maintain hydration status (<1% body mass loss). Our results suggest that coaches and athletes themselves should consider a personalized hydration regimen for adolescent male soccer players, whereas ad libitum drinking seems suitable for females

circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer

Small cell lung cancer (SCLC) is treated as a homogeneous disease, although the expression of NEUROD1, ASCL1, POU2F3, and YAP1 identifies distinct molecular subtypes. The MYC oncogene, amplified in SCLC, was recently shown to act as a lineage-specific factor to associate subtypes with histological classes. Indeed, MYC-driven SCLCs show a distinct metabolic profile and drug sensitivity. To disentangle their molecular features, we focused on the co-amplified PVT1, frequently overexpressed and originating circular (circRNA) and chimeric RNAs. We analyzed hsa_circ_0001821 (circPVT1) and PVT1/AKT3 (chimPVT1) as examples of such transcripts, respectively, to unveil their tumorigenic contribution to SCLC. In detail, circPVT1 activated a pro-proliferative and anti-apoptotic program when over-expressed in lung cells, and knockdown of chimPVT1 induced a decrease in cell growth and an increase of apoptosis in SCLC in vitro. Moreover, the investigated PVT1 transcripts underlined a functional connection between MYC and YAP1/POU2F3, suggesting that they contribute to the transcriptional landscape associated with MYC amplification. In conclusion, we have uncovered a functional role of circular and chimeric PVT1 transcripts in SCLC; these entities may prove useful as novel biomarkers in MYC-amplified tumors.</p

Gender Differences in Hydration Status of Adolescent Soccer Players After Training Sessions

6nonenoneIlaria, Venuto; BUOITE STELLA, ALEX; STEL, Giuliana; Saulle, Mazzolini; FRANCESCATO, Maria Pia; CAUCI, SabinaIlaria, Venuto; BUOITE STELLA, Alex; Stel, Giuliana; Saulle, Mazzolini; Francescato, Maria Pia; Cauci, Sabin

Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts

Pyruvate dehydrogenase kinase 1 (PDK1) blockade triggers are well characterized in vitro metabolic alterations in cancer cells, including reduced glycolysis and increased glucose oxidation. Here, by gene expression profiling and digital pathology-mediated quantification of in situ markers in tumors, we investigated effects of PDK1 silencing on growth, angiogenesis and metabolic features of tumor xenografts formed by highly glycolytic OC316 and OVCAR3 ovarian cancer cells. Notably, at variance with the moderate antiproliferative effects observed in vitro, we found a dramatic negative impact of PDK1 silencing on tumor growth. These findings were associated with reduced angiogenesis and increased necrosis in the OC316 and OVCAR3 tumor models, respectively. Analysis of viable tumor areas uncovered increased proliferation as well as increased apoptosis in PDK1-silenced OVCAR3 tumors. Moreover, RNA profiling disclosed increased glucose catabolic pathways—comprising both oxidative phosphorylation and glycolysis—in PDK1-silenced OVCAR3 tumors, in line with the high mitotic activity detected in the viable rim of these tumors. Altogether, our findings add new evidence in support of a link between tumor metabolism and angiogenesis and remark on the importance of investigating net effects of modulations of metabolic pathways in the context of the tumor microenvironment

Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts

Pyruvate dehydrogenase kinase 1 (PDK1) blockade triggers are well characterized in vitro metabolic alterations in cancer cells, including reduced glycolysis and increased glucose oxidation. Here, by gene expression profiling and digital pathology-mediated quantification of in situ markers in tumors, we investigated effects of PDK1 silencing on growth, angiogenesis and metabolic features of tumor xenografts formed by highly glycolytic OC316 and OVCAR3 ovarian cancer cells. Notably, at variance with the moderate antiproliferative effects observed in vitro, we found a dramatic negative impact of PDK1 silencing on tumor growth. These findings were associated with reduced angiogenesis and increased necrosis in the OC316 and OVCAR3 tumor models, respectively. Analysis of viable tumor areas uncovered increased proliferation as well as increased apoptosis in PDK1-silenced OVCAR3 tumors. Moreover, RNA profiling disclosed increased glucose catabolic pathways—comprising both oxidative phosphorylation and glycolysis—in PDK1-silenced OVCAR3 tumors, in line with the high mitotic activity detected in the viable rim of these tumors. Altogether, our findings add new evidence in support of a link between tumor metabolism and angiogenesis and remark on the importance of investigating net effects of modulations of metabolic pathways in the context of the tumor microenvironment

Additional file 1: of Low back pain and FokI (rs2228570) polymorphism of vitamin D receptor in athletes

Subject N.; LBP_bin, Fok genotype, F1_1_FF, F1_2_Ff, F2_2_ff . Description of data: list of subjects with indication of LBP yes or no, and FokI genotype for each subject. (PDF 16 kb